Latest Moffitt Stories
Tim Moffitt, representing in North Carolina, spent time with Aeroflow Healthcare to get an overview of the Asheville based DME company and to discuss how the ever changing landscape of healthcare
The Ohio State University Comprehensive Cancer Center and Moffitt Cancer Center create ORIEN to accelerate more precise cancer treatments, diagnostics and prevention methods TAMPA,
ConvergeHEALTH, M2Gen and Deloitte will offer personalized medicine studies and real-world analytics services to life sciences organizations, study sponsors and cancer centers
Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute “Libres para Siempre” (“Forever Free®”), a Spanish smoking relapse prevention booklet series.
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.
Researchers at Moffitt Cancer Center who surveyed employees and patients about a ban on outdoor smoking at the cancer center found that 86 percent of non-smokers supported the ban, as did 20 percent of the employees who were smokers.
A description of the projects and studies resulting from a research partnership initiated in 2005 between Moffitt Cancer Center in Tampa, Fla., and the Ponce School of Medicine in Ponce, Puerto Rico, has been published in a recent issue of Health Promotion Practice.
- A trick or prank.